EO 14253 Act of 2025

House Bill

H.R. 3840

119th Congress

EO 14253 Act of 2025

In Committee

Introduced:Jun 9, 2025

Primary Sponsor

Danny K. Davis

Representative

Democratic

IL-7

Cosponsors

1

Quick Stats

Policy Area

Health

Summary

The Ensuring Sufficient Supply of Testing Act would allow the Department of Health and Human Services (HHS) to partner with clinical laboratories as part of maintaining the Strategic National Stockpile. This stockpile contains important medical supplies that can be used in public health emergencies. The bill would expand the types of vendors that HHS can work with to ensure there are enough test kits and other crucial medical products available when needed.

Latest Action

Referred to the Subcommittee on Health.

SponsorDanny K. Davis (D-IL)

Introduced6/9/2025

StatusReferred to the Committee on Natural Resources, and in addition to the Committee on House Administra

ChamberHouse

Data from Congress.gov

See this page through your district lens

Enter ZIP to personalize representatives and vote context.

Stay on top of this issue

Subscribe for weekly bill and representative updates.

Vote Prediction

EO 14253 Act of 2025

The Ensuring Sufficient Supply of Testing Act would allow the Department of Health and Human Services (HHS) to partner with clinical laboratories as part of maintaining the Strategic National Stockpile. This stockpile contains important medical supplies that c

Community Breakdown

Pass

0%

Fail

0%

0 predictions

The Ensuring Sufficient Supply of Testing Act would allow the Department of Health and Human Services (HHS) to partner with clinical laboratories as part of maintaining the Strategic National Stockpile. This stockpile contains important medical supplies that can be used in public health emergencies. The bill would expand the types of vendors that HHS can work with to ensure there are enough test kits and other crucial medical products available when needed.

Bill Number: 3840
Sponsor: Danny K. Davis (D-IL)
Introduced: 6/9/2025
Status: Referred to the Committee on Natural Resources, and in addition to the Committee on House Administra
Policy Area: Health

Data from Congress.gov

AI-generated summary

Fact Sheet

Title: EO 14253 Act of 2025
Bill Number: 3840
Sponsor: Danny K. Davis (D-IL)
Status: Referred to the Committee on Natural Resources, and in addition to the Committee on House Administra
Introduced: 6/9/2025
Summary: The Ensuring Sufficient Supply of Testing Act would allow the Department of Health and Human Services (HHS) to partner with clinical laboratories as part of maintaining the Strategic National Stockpile. This stockpile contains important medical supplies that can be used in public health emergencies.

Data from Congress.gov

AI Summary

Plain-English explanation of this bill

The Ensuring Sufficient Supply of Testing Act would allow the Department of Health and Human Services (HHS) to partner with clinical laboratories as part of maintaining the Strategic National Stockpile. This stockpile contains important medical supplies that can be used in public health emergencies. The bill would expand the types of vendors that HHS can work with to ensure there are enough test kits and other crucial medical products available when needed.

Last updated: 12/30/2025

Official Summary

Congressional Research Service summary

<html><body>Ensuring Sufficient Supply of Testing Act This bill expressly authorizes the Department of Health and Human Services (HHS) to enter into certain contracts and cooperative agreements with clinical laboratories as part of maintaining the Strategic National Stockpile. The Strategic National Stockpile consists of drugs, vaccines, medical products, and other supplies that may be deployed to respond to bioterrorist attacks or other public health emergencies. Current law permits HHS to enter into specified types of contracts and cooperative agreements with vendors (e.g., manufacturers and distributors of medical products) for managing inventory of and ensuring production capacity for supplies needed for the stockpile. The bill specifies that clinical laboratories may participate as vendors in those types of contracts and agreements.</body></html>

Key Points

Main provisions of the bill

Authorizes HHS to enter into contracts and agreements with clinical laboratories for the Strategic National Stockpile
The stockpile contains drugs, vaccines, and other medical supplies for responding to public health crises
Current law allows HHS to work with manufacturers and distributors, this bill adds clinical labs as eligible vendors

How This Impacts Americans

Potential effects on citizens and communities

If this bill becomes law, it could help ensure there are enough COVID-19 tests and other crucial medical products available during future public health emergencies. Clinical laboratories would be able to directly participate in supplying the Strategic National Stockpile, which could increase the overall inventory and production capacity for these important medical resources.

Policy Areas

Primary Policy Area

Health

Related Subjects

Health technology, devices, supplies

Medical tests and diagnostic methods

Public contracts and procurement

Strategic materials and reserves

Scope & Jurisdiction

Jurisdiction Level

federal

Congressional Session

119th Congress

Citation Reference

3840, 119th Congress (2025). "EO 14253 Act of 2025". Source: Voter's Right Platform. https://votersright.org/bills/118-hr-3840

Public Opinions

Community submissions related to this bill.

Share your opinion

No public opinions yet. Be the first to submit one for this bill.

Related Bills in Health

HR 3021

Empowering Patient Choice of Medical Care Act

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means

HR 2111

To amend the Federal Food, Drug, and Cosmetic Act to exempt the premium cigar industry from certain regulations.

Referred to the House Committee on Energy and Commerce.

HR 2884

Anti-Racism in Public Health Act of 2025

Referred to the House Committee on Energy and Commerce.

S 1406

SOAR Act of 2025

Read twice and referred to the Committee on Finance.